Patent Application
Utility
App. No. 18/628,366
· Confirmation No. 5474
METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS)
Applicant:
Salix Pharmaceuticals, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-04-02 | ABN |
Abandonment | 2 | View | |
| 2024-10-17 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2024-10-03 | WELCOME.LET2 |
Welcome Letter from USPTO Commissioner | 1 | View | |
| 2024-09-17 | CTNF |
Non-Final Rejection | 16 | View | |
| 2024-09-17 | 892 |
List of references cited by examiner | 1 | View | |
| 2024-09-17 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2024-09-17 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2024-09-17 | 1449 |
List of References cited by applicant and considered by examiner | 11 | View | |
| 2024-09-17 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2024-09-17 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-09-17 | FOR |
Foreign Reference | 23 | View | |
| 2024-09-17 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2024-08-05 | TRACK1.GRANT |
Track One request Granted | 2 | View | |
| 2024-07-09 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2024-07-09 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-06-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-06-21 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 3 | View | |
| 2024-06-21 | SPEC |
Specification | 63 | View | |
| 2024-06-21 | ABST |
Abstract | 1 | View | |
| 2024-05-28 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-05-28 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-05-08 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2024-05-08 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-05-08 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2024-05-08 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2024-04-05 | A.PE |
Preliminary Amendment | — | View | |
| 2024-04-05 | SPEC |
Specification | — | View | |
| 2024-04-05 | ADS |
Application Data Sheet | 10 | View | |
| 2024-04-05 | PA.. |
Power of Attorney | 2 | View | |
| 2024-04-05 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 11 | View | |
| 2024-04-05 | DRW |
Drawings-only black and white line drawings | 13 | View | |
| 2024-04-05 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2024-04-05 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-04-05 | SPEC |
Specification | 65 | View | |
| 2024-04-05 | CLM |
Claims | 4 | View | |
| 2024-04-05 | ABST |
Abstract | 1 | View | |
| 2024-04-05 | TRACK1.REQ |
Track One Request | 2 | View | |
| 2024-04-05 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2024-04-05 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2024-04-05 | OATH |
Oath or Declaration filed | 2 | View | |
| 2024-04-05 | A.PE |
Preliminary Amendment | 1 | View | |
| 2024-04-05 | CLM |
Claims | 3 | View | |
| 2024-04-05 | SPEC |
Specification | 1 | View | |
| 2024-04-05 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View |
Inventors
William FORBES
Raleigh, NC
Enoch BORTEY
Chapel Hill, NC
Attorneys & Agents of Record
Classification
USPC
514/279
A61K31/437
Prosecution
- Examiner
- SCHMITT, MICHAEL J
- Art Unit
- 1629
- Customer No.
- 193452
- Docket No.
- 134003-5027-US10
- Confirmation No.
- 5474
Publication
- Pub. No.
- US20240342142A1
- Pub. Date
- 2024-10-17
Parent
is a Continuation of
→
App. 18/241,355
Filed 2023-09-01
· Response to Non-Final Office Action Entered and Forwarded to Examiner
Parent
is a Continuation of
→
App. 17/197,561
· US 11,779,571
Filed 2021-03-10
· Patented Case
Parent
is a Continuation of
→
App. 16/944,956
Filed 2020-07-31
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/738,392
· US 10,765,667
Filed 2020-01-09
· Patented Case
Parent
is a Continuation of
→
App. 16/575,769
Filed 2019-09-19
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/902,179
· US 10,456,384
Filed 2018-02-22
· Patented Case
Parent
is a Continuation of
→
App. 15/398,283
· US 9,931,325
Filed 2017-01-04
· Patented Case
Parent
is a Continuation of
→
App. 13/755,578
· US 9,566,270
Filed 2013-01-31
· Patented Case
Parent
is a Continuation of
→
App. 12/880,739
Filed 2010-09-13
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 61/329,511
Filed 2010-04-29
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/262,475
Filed 2009-11-18
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/241,945
Filed 2009-09-13
· Provisional Application Expired
Parent
is a Continuation in-part of
→
App. 12/393,979
· US 8,309,569
Filed 2009-02-26
· Patented Case
Parent
Claims priority from a provisional application
→
App. 61/102,801
Filed 2008-10-03
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 61/031,679
Filed 2008-02-26
· Provisional Application Expired
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2024-09-03
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2024-09-03
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2024-09-03
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/628,366
- Filed
- 2024-04-05
- Pub. No.
- US20240342142A1
- Examiner
- SCHMITT, MICHAEL J
- Art Unit
- 1629
External Links